Viewing Study NCT00122304


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-29 @ 6:13 PM
Study NCT ID: NCT00122304
Status: COMPLETED
Last Update Posted: 2007-02-21
First Post: 2005-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module